279 related articles for article (PubMed ID: 11818152)
1. Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis.
Beyer WE; Palache AM; de Jong JC; Osterhaus AD
Vaccine; 2002 Jan; 20(9-10):1340-53. PubMed ID: 11818152
[TBL] [Abstract][Full Text] [Related]
2. The humoral response to live and inactivated influenza vaccines administered alone and in combination to young adults and elderly.
Stepanova L; Naykhin A; Kolmskog C; Jonson G; Barantceva I; Bichurina M; Kubar O; Linde A
J Clin Virol; 2002 Apr; 24(3):193-201. PubMed ID: 11856620
[TBL] [Abstract][Full Text] [Related]
3. [Advantages and disadvantages of inactivated and live influenza vaccine].
Gendon IuZ
Vopr Virusol; 2004; 49(4):4-12. PubMed ID: 15293504
[TBL] [Abstract][Full Text] [Related]
4. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory.
Powers DC; Fries LF; Murphy BR; Thumar B; Clements ML
J Clin Microbiol; 1991 Mar; 29(3):498-505. PubMed ID: 2037667
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease.
Edwards KM; Dupont WD; Westrich MK; Plummer WD; Palmer PS; Wright PF
J Infect Dis; 1994 Jan; 169(1):68-76. PubMed ID: 8277200
[TBL] [Abstract][Full Text] [Related]
6. Randomized trial comparing the safety and antibody responses to live attenuated versus inactivated influenza vaccine when administered to breastfeeding women.
Brady RC; Jackson LA; Frey SE; Shane AL; Walter EB; Swamy GK; Schlaudecker EP; Szefer E; Wolff M; McNeal MM; Bernstein DI; Steinhoff MC
Vaccine; 2018 Jul; 36(31):4663-4671. PubMed ID: 29961606
[TBL] [Abstract][Full Text] [Related]
7. Correlates of immune protection induced by live, attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine.
Belshe RB; Gruber WC; Mendelman PM; Mehta HB; Mahmood K; Reisinger K; Treanor J; Zangwill K; Hayden FG; Bernstein DI; Kotloff K; King J; Piedra PA; Block SL; Yan L; Wolff M
J Infect Dis; 2000 Mar; 181(3):1133-7. PubMed ID: 10720541
[TBL] [Abstract][Full Text] [Related]
8. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
[TBL] [Abstract][Full Text] [Related]
9. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults.
Treanor JJ; Roth FK; Betts RF
J Clin Microbiol; 1990 Mar; 28(3):596-9. PubMed ID: 2182673
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience.
Neuzil KM; Dupont WD; Wright PF; Edwards KM
Pediatr Infect Dis J; 2001 Aug; 20(8):733-40. PubMed ID: 11734733
[TBL] [Abstract][Full Text] [Related]
11. Human immune responses to influenza virus vaccines administered by systemic or mucosal routes.
Moldoveanu Z; Clements ML; Prince SJ; Murphy BR; Mestecky J
Vaccine; 1995 Aug; 13(11):1006-12. PubMed ID: 8525683
[TBL] [Abstract][Full Text] [Related]
12. Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013-2014 season.
King JP; McLean HQ; Meece JK; Levine MZ; Spencer SM; Flannery B; Belongia EA
Vaccine; 2018 Feb; 36(9):1214-1219. PubMed ID: 29395525
[TBL] [Abstract][Full Text] [Related]
13. An Intranasal Proteosome-Adjuvanted Trivalent Influenza Vaccine Is Safe, Immunogenic & Efficacious in the Human Viral Influenza Challenge Model. Serum IgG & Mucosal IgA Are Important Correlates of Protection against Illness Associated with Infection.
Lambkin-Williams R; Gelder C; Broughton R; Mallett CP; Gilbert AS; Mann A; He D; Oxford JS; Burt D
PLoS One; 2016; 11(12):e0163089. PubMed ID: 28005959
[TBL] [Abstract][Full Text] [Related]
14. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults.
Keitel WA; Cate TR; Nino D; Huggins LL; Six HR; Quarles JM; Couch RB
J Infect Dis; 2001 Jan; 183(2):329-332. PubMed ID: 11110645
[TBL] [Abstract][Full Text] [Related]
15. A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.
Talaat KR; Karron RA; Callahan KA; Luke CJ; DiLorenzo SC; Chen GL; Lamirande EW; Jin H; Coelingh KL; Murphy BR; Kemble G; Subbarao K
Vaccine; 2009 Jun; 27(28):3744-53. PubMed ID: 19464558
[TBL] [Abstract][Full Text] [Related]
16. Advantage of live attenuated cold-adapted influenza A virus over inactivated vaccine for A/Washington/80 (H3N2) wild-type virus infection.
Clements ML; Betts RF; Murphy BR
Lancet; 1984 Mar; 1(8379):705-8. PubMed ID: 6143042
[TBL] [Abstract][Full Text] [Related]
17. Systemic and local antibody responses in elderly subjects given live or inactivated influenza A virus vaccines.
Powers DC; Sears SD; Murphy BR; Thumar B; Clements ML
J Clin Microbiol; 1989 Dec; 27(12):2666-71. PubMed ID: 2592535
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy and safety of live attenuated cold-adapted influenza vaccine, trivalent, with trivalent inactivated influenza virus vaccine in children and adolescents with asthma.
Fleming DM; Crovari P; Wahn U; Klemola T; Schlesinger Y; Langussis A; Øymar K; Garcia ML; Krygier A; Costa H; Heininger U; Pregaldien JL; Cheng SM; Skinner J; Razmpour A; Saville M; Gruber WC; Forrest B;
Pediatr Infect Dis J; 2006 Oct; 25(10):860-9. PubMed ID: 17006278
[TBL] [Abstract][Full Text] [Related]
19. Superior relative efficacy of live attenuated influenza vaccine compared with inactivated influenza vaccine in young children with recurrent respiratory tract infections.
Ashkenazi S; Vertruyen A; Arístegui J; Esposito S; McKeith DD; Klemola T; Biolek J; Kühr J; Bujnowski T; Desgrandchamps D; Cheng SM; Skinner J; Gruber WC; Forrest BD;
Pediatr Infect Dis J; 2006 Oct; 25(10):870-9. PubMed ID: 17006279
[TBL] [Abstract][Full Text] [Related]
20. Development and persistence of local and systemic antibody responses in adults given live attenuated or inactivated influenza A virus vaccine.
Clements ML; Murphy BR
J Clin Microbiol; 1986 Jan; 23(1):66-72. PubMed ID: 3700610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
